Search

everythinglearnresearchcommunity

for

Search:↓

Proinflammatory fibroblasts and vascular endothelial cells are key in keloid development.

Targeted immune modulation can help achieve stable remission in alopecia areata.

Composite biomaterials can precisely control immune responses for better disease treatment.

Chemotherapy-induced hair loss is partly due to decreased laminin-511 and increased laminin-332.

The patient had paraneoplastic pemphigus without mucosal involvement.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

BTNL2 helps protect hair follicles from immune attacks.

A woman's psoriasis improved after hepatitis C treatment with interferon, despite interferon's risk of worsening skin conditions.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

Blocking certain immune signals can reduce skin damage from radiation therapy.

Contact immunotherapy might help treat various skin conditions, but more research is needed to confirm its safety and effectiveness.

IL-18 signaling helps mature Tregs move into the thymus.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

A young woman with visual issues and other symptoms was diagnosed with lupus and antiphospholipid syndrome, and improved with treatment.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

JAK inhibitors show promise for treating skin diseases effectively and safely.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

GLPLS and LPP are variants of lichen planus.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.